An Artificial Intelligence Multimodal Method for Patient Outcome Prediction
During the 2023 Annual Congress of the European Association for Cancer Research (EACR 2023), Dr. Daoud Meerzaman, NCI CBIIT’s Computational Genomics and Bioinformatics Branch chief, will discuss how multimodal artificial intelligence and machine learning approaches can predict cancer patient outcomes. His approach involves the integration of multiple data modalities to improve the accuracy and effectiveness of predictions.
If you’re attending the congress, be sure to attend his presentation!
Dr. Meerzaman will integrate information from various sources such as clinical data, medical imaging, genomics, and other relevant data to provide a comprehensive understanding of a Glioblastoma (GBM) patient’s health status, progression, or response to treatment.
EACR 2023 is a conference dedicated to basic, preclinical, and translational cancer research across a wide breadth of topics. This event will bring together the cancer research community to inspire innovation and build knowledge, connections, and collaborations.
Dr. Meerzaman is the Computational Genomics and Bioinformatics Branch (CGBB) chief at CBIIT. Under his supervision, CGBB provides bioinformatics analysis support for life sciences and clinical and translational research for intramural scientists, including both NCI’s Division of Cancer Epidemiology and Genetics and Center for Cancer Research.
Upcoming Events
- Predicting Patients’ Response to Immunotherapy from Tumor Histopathology and Blood: Computational Science in Immuno-oncologyJuly 08, 2025Assessing the Tumor Microenvironment with Systems Immunology: Computational Science in Immuno-oncologyAugust 21, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025NCI Office of Data Sharing’s Annual Data Sharing Symposium 2025: How Data Advances the Impact of Cancer ResearchSeptember 30, 2025 - October 01, 2025Childhood Cancer Data Initiative (CCDI) Symposium 2025October 06, 2025 - October 07, 2025